CClinicalTrials.gg
CompletedNCT01313949PLATINUMUpdated Jul 23, 2014

PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 Diabetes

An interventional study of Training program in Diabetes, sponsored by Asia Diabetes Foundation. Completed at 15 sites in Hong Kong. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2014-07-23.

Sponsored by Asia Diabetes Foundation · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Non-randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The investigators hypothesize that a training course to people with diabetes on peer support and empowerment will improve their glycemic parameters, knowledge on diabetes and level of self efficacy. This group of trained patients (peer leaders) should be competent to teach and help other patients with diabetes through peer support and empowerment on better self management of their diabetes.

Read the detailed description

In our attempt to improve diabetes self care, one important component is the diabetes patients who should have the best incentive to improve their care levels and reduce their complication risk, provided that they are appropriately trained, informed, educated and supported. According to the World Health Organization (WHO) Innovative Care for Chronic Conditions framework, expert patients are recommended to be included in the health care team to make them prepared, motivated and informed decision makers to preserve health and improve clinical outcomes. In a recent report on WHO consultation, peer support interventions are considered to have enormous potentials to make self management an effective component of chronic care.

Peer support is defined as support from a person who has experiential knowledge of a specific behavior or stressor and similar characteristics as the target population. Thus people with common illness experience can share knowledge and experience in a less hierarchical and reciprocal relationship compared to that between patients and health care professionals. A number of programs including health worker-led groups with peer exchange, peer-led face-to-face self management programs, peer coaches and remote peer support have reported encouraging results with short term improvement in metabolic or cognitive-psychological-behavioral dimensions, although these results are often limited by non-sustainability of changes and insufficient reach or adoption of programs by patients or health care workers. In the WHO report, health care experts from various disciplines concluded that whilst peer support is a promising approach for diabetes management, issues regarding methods of organization, types of programs and their integration with other clinical and outreach services remain to be addressed. Of note, there is a paucity of similar data in developing and low income areas which are hit hardest by this epidemic and where peer support program may offer great promise to make diabetes prevention and care program more sustainable and accessible, if implemented and evaluated systematically.

Health professionals, especially diabetes nursing specialists, have been training diabetes patients on the understanding and self-caring of diabetes. However, with the emerging concept and preliminary evidence of success in the role of "peer advisors" in diabetes to lead self care courses for other fellow patients, a train-the-trainer program to develop "expert patients" is essential. On top of factual knowledge on diabetes as a disease, context of this program needs to cover include communication and empowerment skill, basic knowledge on psychology, stress management, social support, empowerment, healthy lifestyle including diet and physical activity.

In the evaluation of the programs, there is a need to define the qualities and roles of the peer supporter, design programs which integrate and complement formal health services, identify optimal mix of modalities of intervention, types and dose response of these interventions and evaluate acceptability and effectiveness of these programs in different cultures. Other evaluation indexes include effects of programs on behavioral changes, knowledge and attitudes, functionality, clinical care as well as their cost effectiveness, reach, implementation-consistency, adoption and maintenance of effects over time.

02

Conditions studied

  • Diabetes

Browse trials for

Keywords

  • Diabetes
  • Peer Support
  • Structured Care
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 75 is close to the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Asia Diabetes Foundation is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chinese people with type 2 diabetes
  • 18-75 years of age
  • Good glycaemic control (HbA1c \<7%) and remain stable in past 1 year
  • Willing to complete the structured training curriculum to prepare themselves as peer leaders
  • Fluent in Cantonese

Exclusion criteria

Exclusion Criteria:

  • Known psychiatric disease
  • Physically handicapped to the degree that communication with others is significantly impaired impaired, such as deafness, paraplegia.
  • Illiterate
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (actual)

Study arms

  • No intervention
    Usual Care

    A total of 90 patients with diabetes will be recruited. Thirty will be selected for the training course and the other 60 will be compared as controls. These controls will receive their usual diabetes care.

  • Experimental
    Peer leader training

    Peer leaders are people with diabetes who had volunteered to undertake an extensive program of training. The purpose of this training is to make them effective in the provision of support and advice to their peers on a one-to-one basis via telecommunication. These diabetes patients will undergo a 32-hour 'Train the trainer' program (4 workshops, 8-hours each) led by health care experts in nutrition, physical activity, psychology and neuro-linguistic program \[NLP\] trainer to ensure the adequacy of knowledge and skills of these mentors.

    Other: Training program

Interventions

  • OtherTraining program

    These diabetes patients will undergo a 32-hour 'Train the trainer' program (4 workshops, 8-hours each) led by health care experts in nutrition, physical activity, psychology and neuro-linguistic program \[NLP\] trainer to ensure the adequacy of knowledge and skills of these mentors.

06

What researchers measure

Primary outcomes

  1. To assess the effectiveness of the training program in improving glycemic parameters in diabetic patients before and after the training.

    Metabolic parameters, such as HbA1c, Body Mass Index (BMI), Lipid Profile, etc. will be measured at specific time points before and after the training

    Time frame: 6 months

Secondary outcomes

  1. To assess the efficacy of the training on the attitudes, behaviours and self-efficacy of the participants as compared to the control patients

    The psychosocial-behavior assessment will include using the Summary of Diabetes Self- Care Activities (SDSCA), Diabetes Empowerment Scale (DES), Depression Anxiety Stress Scale-21 (DASS21), General Health Questionnaire (GHQ12), Euro Quality of Life (EQ5D) \& Patient Health Questionniare (PHQ9).

    Time frame: 6 months

  2. To assess the efficacy of the training in improving the participants' knowledge of diabetes, as compared to the control patients.

    An evaluation feedback form will be completed by all participants after each workshop

    Time frame: 6 months

07

Study locations

15 sites
  • Diabetes Ambulatory Care Centre, UCH
    Kwun Tong, Kowloon, Hong Kong
  • Kwai Chung out-patient clinic
    Kwai Chung, New Territories, Hong Kong
  • CUHK YCK, Prince of Wales Hospital
    Shatin, New Territories, Hong Kong
  • Diabetes & Endocrine Centre, Prince of Wales Hospital
    Shatin, New Territories, Hong Kong
  • Diabetes Centre, North District Hospital
    Sheung Shui, New Territories, Hong Kong
  • Diabetes Centre, Tung Wah Eastern Hospital
    Causeway Bay, Hong Kong
  • Diabetes Hong Kong
    Central, Hong Kong
  • Diabetes Ambulatory Centre, PYNEH
    Chai Wan, Hong Kong
  • Diabetes Centre, Kwong Wah Hospital
    Kowloon, Hong Kong
  • Diabetes Centre, Queen Elizabeth Hospital
    Kowloon, Hong Kong
  • PMH, Diabetes Care Centre, Princess Margaret Hospital
    Kowloon, Hong Kong
  • Lam Tin Health Clinic
    Lam Tin, Hong Kong
  • Diabetes Centre, Queen Mary Hospital
    Pok Fu Lam, Hong Kong
  • Sai Wan Ho Health Centre
    Sai Wan Ho, Hong Kong
  • Diabetes Centre, Ruttonjee Hospital
    Wan Chai, Hong Kong
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01313949
Lead sponsor
Asia Diabetes Foundation
Responsible party
Sponsor
First posted
Mar 14, 2011
Start date
Feb 2009
Primary completion
Feb 2011
Completion
Aug 2011
Last update
Jul 23, 2014

Study contacts

Rebecca Wong
principal investigator · Prince of Wales Hospital, Shatin, HK
Shimen Au
principal investigator · Ruttonjee & Tang Shiu Kin Hospitals, Wan Chai, HK

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion